The Food and Drug Administration (FDA) has advised the Department of Health (DoH) to stop giving the AZD1222 vaccine of British-Swedish drugmaker AstraZeneca to persons below 60 years old.

The recommendation comes after the European Medicines Agency (EMA) announced on Wednesday that it found “possible links” between the vaccine and blood clots in 16 cases across Europe.